Asset Details
Do you wish to reserve the book?
Latin America’s embrace of an unproven COVID treatment is hindering drug trials
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Latin America’s embrace of an unproven COVID treatment is hindering drug trials
Do you wish to request the book?
Latin America’s embrace of an unproven COVID treatment is hindering drug trials
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Latin America’s embrace of an unproven COVID treatment is hindering drug trials
2020
Overview
Unchecked ivermectin use in the region is making it difficult to test the anti-parasite drug’s effectiveness against the coronavirus.
Latin America’s embrace of unproven COVID treatment hinders drug trials
Unchecked ivermectin use in region is making it difficult to test anti-parasite drug’s effectiveness against the coronavirus.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ 692/308
/ 692/699
/ 692/700
/ Animals
/ Clinical Trials as Topic - standards
/ Coronavirus Infections - drug therapy
/ Coronavirus Infections - epidemiology
/ Coronavirus Infections - prevention & control
/ COVID-19
/ Humans
/ Ivermectin - administration & dosage
/ Ivermectin - adverse effects
/ Ivermectin - therapeutic use
/ Latin America - epidemiology
/ News
/ Pandemics - prevention & control
/ Pneumonia, Viral - drug therapy
/ Pneumonia, Viral - epidemiology
/ Pneumonia, Viral - prevention & control
/ Retraction of Publication as Topic
/ Testing
